SPIA
TXG icon

Steward Partners Investment Advisory’s 10x Genomics TXG Stock Holding History

Steward Partners Investment Advisory’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.55K Buy
197
+58
+42% +$1.52K ﹤0.01% 3835
2026
Q1 		$2.95K Sell
139
-16,873
-99% -$337K ﹤0.01% 3942
2025
Q4 		$277K Buy
17,012
+16,873
+12,139% +$255K ﹤0.01% 1754
2025
Q3 		$1.63K Buy
139
+39
+39% +$509 ﹤0.01% 3975
2025
Q2 		$1.16K Hold
100
– – ﹤0.01% 3834
2025
Q1 		$873 Hold
100
– – ﹤0.01% 3795
2024
Q4 		$1.44K Sell
100
-148
-60% -$2.34K ﹤0.01% 3704
2024
Q3 		$5.6K Buy
+248
New +$5.13K ﹤0.01% 3150
2022
Q4 		– Sell
-4
Closed – – 3455
2022
Q3 		$0 Sell
4
-4
-50% -$152 ﹤0.01% 3384
2022
Q2 		$0 Hold
8
– – ﹤0.01% 3373
2022
Q1 		$1K Buy
+8
New +$700 ﹤0.01% 3228
2021
Q3 		– Sell
-207
Closed -$41K – 3335
2021
Q2 		$41K Sell
207
-2,125
-91% -$385K ﹤0.01% 3739
2021
Q1 		$422K Sell
2,332
-7,972
-77% -$1.38M 0.01% 948
2020
Q4 		$1.46M Sell
10,304
-764
-7% -$111K 0.03% 443
2020
Q3 		$1.38M Sell
11,068
-5,423
-33% -$569K 0.03% 400
2020
Q2 		$1.47M Buy
+16,491
New +$1.28M 0.04% 363

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steward Partners Investment Advisory's TXG Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its 10x Genomics (TXG) stake by 42% in Q2 2026, buying an estimated $1.52K and bringing the position to 197 shares worth $7.55K. The position accounts for ﹤0.01% of the portfolio, ranked #3835.

Steward Partners Investment Advisory first reported a position in TXG in Q2 2020 and has held it in 16 quarters since. The position peaked at $1.47M in Q2 2020. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Steward Partners Investment Advisory held 197 shares of 10x Genomics worth $7.55K as of Q2 2026.
  • Steward Partners Investment Advisory bought 58 10x Genomics shares in Q2 2026, an estimated $1.52K.
  • 10x Genomics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3835 holding.
  • Steward Partners Investment Advisory first reported a position in 10x Genomics in Q2 2020 and has held it in 16 quarters since.
  • Steward Partners Investment Advisory's 10x Genomics position peaked at $1.47M in Q2 2020.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.